Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × atezolizumab × 90 days × Clear all

Phase

Status

Sponsor Class

INDUSTRY 67 OTHER 57 NIH 23 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Capecitabine 4 tislelizumab 3 pembrolizumab 3 Radiosurgery 3 Bevacizumab 3 Oxaliplatin 2 Metformin 2 Drug Therapy 2 trilaciclib 1 trastuzumab deruxtecan 1 spartalizumab 1 lenvatinib 1 ivarmacitinib 1 ferric maltol 1 defactinib 1 decitabine and cedazuridine drug combination 1 dalpiciclib 1 cedazuridine 1 bemarituzumab 1 atezolizumab 1 anlotinib 1 XELOX 1 Vitamin D 1 Videotape Recording 1 Tranexamic Acid 1 Synbiotics 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07293468 2025-12-19

BIIRTH

Tuen Mun Hospital

Phase 2/3 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡